Inhibition of Mycoplasma Pneumoniae Growth by FDA-approved Anticancer and Antiviral Nucleoside and Nucleobase Analogs

BMC Microbiology - United Kingdom
doi 10.1186/1471-2180-13-184
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antiviral Nucleoside and Nucleotide Analogs: A Review

Journal of Advanced Pharmacy Research
2018English

The Inhibition of Platycodin D on Mycoplasma Pneumoniae Proliferation and Its Effect on Promoting Cell Growth After Anti-Mycoplasma Pneumoniae Treatment

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2015English

ILP-2 Modeling and Virtual Screening of an FDA-approved Library:a Possible Anticancer Therapy

Turkish Journal of Medical Sciences
Medicine
2016English

Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2004English

Catalase Enhances Growth and Biofilm Production of Mycoplasma Pneumoniae

Current Microbiology
Applied MicrobiologyBiotechnologyMicrobiologyMedicine
2015English

FDA-Approved Biosimilar Insulin

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2014English

A Review on the Drugs Approved by US-FDA and DCGI

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
2016English

Rhombencephalitis Possibly Caused by Mycoplasma Pneumoniae

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2010English

Drug Development Process and Novel Drugs Approved by FDA for 2017 -18

Applied Clinical Research, Clinical Trials and Regulatory Affairs
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy